TNP
Calculate developability metrics from nanobody (VHH) sequences. Use them to compare candidate properties; they do not guarantee successful drug development.
API/CLI tool ID: tnp
Understanding inputs and outputs
A nanobody, also called a VHH, is a small antibody that recognizes a target through a single variable domain. This TNP result table flags sequence positions that may be susceptible to chemical modification. liability classifies sequence patterns; it is not evidence that a modification occurred or a verdict that drug development will fail.
For multiple FASTA records, distinguish sequences by sequence_id and read chain together with position. position follows antibody numbering, so preserve insertion letters and distinguish it from sequential position. One position can carry several liability types; row counts are neither counts of distinct positions nor modification rates.
Input settings
| Setting | Format | Required | Default | Description and constraints |
|---|---|---|---|---|
inputFormat | dropdown | Optional | "sequence" | Input format — sequence enters one sequence directly, fasta uses a FASTA file — Allowed values sequence · fasta |
sequence | sequence | Conditionally required | — | Nanobody sequence — Characters ACDEFGHIKLMNPQRSTVWY , maximum length 160 — Applies when: inputFormat = "sequence" |
sequenceFile | fasta | Conditionally required | — | Nanobody (VHH) FASTA (1–20 sequences, 70–160 residues each, up to 64 KiB). Sequence IDs use letters, digits, _ or -, up to 64 characters, and appear unchanged in sequence_id — Extensions fasta · fa — Applies when: inputFormat = "fasta" |
Result fields
| Column | Display name | Description |
|---|---|---|
sequence_id | Sequence ID | FASTA record ID; sequence when one sequence is entered directly |
chain | Chain | — |
position | Residue number | Number assigned by the model. Keeps insertion letters and the original notation, and may differ from sequence order. |
aa | Amino acid | — |
liability | Chemical liability | A possible modification flagged by sequence pattern. Doesn't mean the modification actually occurs, and isn't an experimental result. |
Sequences, chain types and category names are not numerical scores. Interpret what each field describes rather than ranking its value.
Execution availability
Open an execution plan in your project to see available tool versions and costs. Review and approve the inputs, settings, and terms before running.
License
Code, model weights, and accompanying data have their own terms. The table summarizes terms from official sources; check your execution plan for the configuration you will use. License texts are available in Third-party notices.
| Component | License | Commercial use | Source | Notes |
|---|---|---|---|---|
| Code | BSD-3-Clause | Allowed, subject to notice requirements | License text | — |
| Data | CC-BY-4.0 | Conditional; see notes | Official terms and distribution information | Reference data derived from IMGT sequences is covered by CC BY 4.0. Research and commercial use require attribution. Using the IMGT name for promotion requires prior written approval. |
| Model weights | CC-BY-4.0 | Conditional; see notes | Weight distribution metadata | The NanoBodyBuilder2 weights used for structure modeling require attribution under CC BY 4.0. |
| Code | MIT AND LGPL-3.0-only | Conditional; see notes | License text | OpenMM 8.6.1 and pdbfixer are used to prepare structures. Distributing the image to customers is subject to LGPL distribution requirements, including source availability. |
TNP uses ANARCI, ImmuneBuilder, and OpenMM, so their terms also apply. The current tool reference defines the available functions and inputs.
Checked on 2026-10-31.